Llwytho...
PD-1/PD-L1 Blockade in Renal Cell Cancer
INTRODUCTION: Immunotherapy using checkpoint inhibitors is providing significant benefit to patients with renal cell carcinoma (RCC), both in overall survival and tolerability of treatment. Given the recent approval of the first checkpoint inhibitor in RCC, this review discusses the background and c...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Rev Clin Immunol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555220/ https://ncbi.nlm.nih.gov/pubmed/27426025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1744666X.2016.1214575 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|